Technology | May 14, 2015

EOS Imaging Launches EOS 3D Service

Montreal-based online modeling service to provide personalized 3-D data from EOS stereo-radiographic patient images

EOS, 3D Service, 3-D modeling, stereo-radiographic images

May 14, 2015 — EOS Imaging announced a new online service offering that allows hospitals to outsource 3-D modeling from EOS stereo-radiographic images. The 3-D models will be generated at EOS’ Canadian subsidiary in Montreal.

The 3-D models and associated, automatically computed clinical data will be available for spine, hip and knee for aid in therapeutic decision, surgery planning and control. EOS 3D Service will also provide 3-D modeling of the ribcage for research purposes as well as for the design of scoliosis braces.

EOS has already begun to offer this new service, and a first agreement has been signed with the Setting Scoliosis Straight Foundation (SSSF). SSSF is a not-for-profit foundation that supports the Harms Study Group (HSG) in understanding and developing treatments of spinal deformities in children and adolescents. HSG, formed in 1995, is a collaborative cohort of worldwide surgeons who perform comprehensive, multi-center research studies and share the results to advance the techniques of spinal deformity correction. EOS 3D Service to SSSF allows the Harms Study Group surgeons access to 3-D data for their patients undergoing scoliosis surgery. 

“EOS' modeling capabilities fit seamlessly into our strategic plan to research and identify new spinal deformity treatment techniques and we couldn't be more pleased to partner with the company as the first users of the EOS 3D Service” said Michelle Marks, executive director of the SSSF.

The EOS system provides full-body stereo-radiographic images of patients in functional positions, in both 2-D and 3-D, as well as related software solutions. EOS exams require a radiation dose 50-85 percent less than digital radiology and 95 percent less than basic computed tomography (CT) scans. The new EOS Micro Dose option, recently cleared by the U.S. Food and Drug Administration, allows a further drastic step towards the ALARA (As Low As Reasonably Achievable) principle by bringing pediatric spine follow-up exams at a dose level equivalent to a week of natural background radiation on Earth.

For more information: www.eos-imaging.com

Related Content

RSNA and ACR to Collaborate on Landmark Medical 3D Printing Registry
News | Medical 3-D Printing | August 08, 2019
The Radiological Society of North America (RSNA) and the American College of Radiology (ACR) will launch a new medical...
Synaptive Medical Launches Modus Plan With Automated Tractography Segmentation
Technology | Neuro Imaging | August 07, 2019
Synaptive Medical announced the U.S. launch and availability of Modus Plan featuring BrightMatter AutoSeg. This release...
TeraRecon Unveils iNtuition AI Data Extractor
News | Advanced Visualization | July 03, 2019
Artificial Intelligence (AI) and advanced visualization company TeraRecon announced its new iNtuition AI Data Extractor...
A 3-D printed model (left) and a model constructed in augmented reality (right), both of a kidney with a tumor. In both models, the kidney is clear; the tumor is visible in purple on the AR model and in white on the 3-D printed model.

A 3-D printed model (left) and a model constructed in augmented reality (right), both of a kidney with a tumor. In both models, the kidney is clear; the tumor is visible in purple on the AR model and in white on the 3-D printed model. Photo courtesy of Nicole Wake, Ph.D.

Feature | Advanced Visualization | July 02, 2019 | By Jeff Zagoudis
Three-dimensional (3-D) printing and...

Image courtesy of Philips Healthcare

Feature | Molecular Imaging | July 01, 2019 | By Sharvari Rale
Diagnostic procedures have always been a cornerstone of early prognosis and patient triaging.
TeraRecon Receives FDA Clearance for Northstar AI Results Explorer
Technology | Artificial Intelligence | June 20, 2019
Advanced visualization and artificial intelligence (AI) technology provider TeraRecon has successfully completed a U.S...
Materialise Receives FDA Clearance for Cardiovascular Planning Software Suite
Technology | Advanced Visualization | June 13, 2019
Three-dimensional (3-D) printing software and solutions company Materialise has received U.S. Food and Drug...
Konica Minolta Healthcare Announces Autologous Biologics Workshop in Partnership With EmCyte Corp.
News | Ultrasound Imaging | June 12, 2019
Konica Minolta Healthcare announced a new autologous biologics workshop in partnership with EmCyte Corp. The workshop...
Aidoc Earns FDA Approval for AI for C-spine Fractures
Technology | Artificial Intelligence | June 11, 2019
Radiology artificial intelligence (AI) provider Aidoc announced the U.S. Food and Drug Administration (FDA) has cleared...
Medivis SurgicalAR Gets FDA Clearance
Technology | Virtual and Augmented Reality | June 10, 2019
Medivis announced that its augmented reality (AR) technology platform for surgical applications, SurgicalAR, has...